Chun-Rong Tong
Overview
Explore the profile of Chun-Rong Tong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang W, Tong C, Wu T, Lin Y, Li C
Blood Cell Ther
. 2023 Jan;
3(4):71-73.
PMID: 36711005
Precursor B-cell acute lymphoblastic leukemia (pre-B ALL) relapse after allogeneic hematopoietic stem cell transplantation (HSCT) typically has poor outcomes. Both bispecific T-cell engager (BiTE, blinatumomab) and chimeric antigen receptor T-cell...
2.
Pan J, Zhang Y, Zhao Y, Yang J, Zhang J, Liu H, et al.
Leuk Lymphoma
. 2016 Nov;
58(7):1655-1663.
PMID: 27874290
We report the clinical features and outcome of 22 TLS-ERGleukemia patients (20 AML and 2 B-ALL). TLS-ERG was tightly associated with extramedullary disease (EMD), complex chromosome abnormalities, and high risk...
3.
Pan J, Yang J, Tong C
Zhongguo Dang Dai Er Ke Za Zhi
. 2014 Nov;
16(11):1168-9.
PMID: 25406566
No abstract available.
4.
Wang T, Gao W, Liu H, Teng W, Ren J, Wang C, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2013 Dec;
34(12):1028-31.
PMID: 24369159
Objective: To report two de novo acute myeloid leukemia (AML) patients with t(11;22)(q23;q11.2) and summarize the clinical and biological characteristics. Methods: Bone marrow cells morphology, immunophenotype, chromosome karyotype, fluorescence in...
5.
Wang T, Cao W, Yin Y, Zhang Y, Zhang Q, Wang C, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2013 Dec;
34(11):974-6.
PMID: 24294857
No abstract available.
6.
Wang J, Wu T, DA W, Tong C, Sun Y, Zhao Y, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2012 Sep;
33(6):467-70.
PMID: 22967382
Objective: To evaluate the efficacy of salvaged allogeneic hematopoietic stem cell transplantation (allo-HSCT) for refractory/recurrent acute myeloid leukemia (AML). Methods: A total of 45 patients with refractory/recurrent AML were enrolled...
7.
Fei X, Wu S, Sun R, Zhou J, Wang J, Wang T, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2012 Jun;
20(3):545-8.
PMID: 22739152
This study was purposed to analyze the characteristics of morphology, immunology, cytogenetic and molecular biology of leukemia cells in 12 AML patients with Ph(+) and their correlation with survival of...
8.
Gao Y, Wu T, Wang H, Tong C, Zhang W, Wang J, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2012 Jun;
33(2):84-7.
PMID: 22730653
Objective: To study the significance of flow cytometric monitoring minimal residual diseases (MRD) in patients with acute leukemia (AL) after allogeneic hemapoietic stem cell transplantation (HSCT). Methods: From January 2007...
9.
Tong C, Wang H, Yang J, Lin Y, Zhang X, Zhao J, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2012 Feb;
32(11):748-51.
PMID: 22339910
Objective: To study the predictable value of monitoring minimal residual disease (MRD) regularly by flow cytometry (FCM) in patients with acute leukemia (AL) in the first complete remission (CR(1)). Methods:...
10.
Zhang X, Zhang Y, Wang J, Tong C, Cai P, Liu H, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2012 Feb;
32(8):525-8.
PMID: 22338174
Objective: To investigate the effect of inhibitory and activating KIRs on a cohort of Chinese leukemia patients who received haplo-identical hematopoietic stem cell transplantation (HSCT). Methods: Donor's inhibitory and activating...